Drug · DIN 02408996
CLARITHROMYCIN
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since June 6, 2023; first marketed September 5, 2013.
- Drug Identification Number (DIN)
- 02408996
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Granules For Suspension
- Route
- Oral
- Therapeutic class (ATC)
- Clarithromycin J01FA09
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CLARITHROMYCIN | 250 MG | 5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 26, 2013: NOC 14594New Drug Submission (NDS) · Administrative licensing agreement between two companies
Other DINs named CLARITHROMYCIN
- DIN 02442469 · Marketed
- DIN 02442485 · Marketed
- DIN 02466120 · Marketed
- DIN 02466139 · Marketed
- DIN 02390116 · Cancelled Pre Market
- DIN 02390191 · Cancelled Pre Market
- DIN 02408988 · Dormant